Diabetes mellitus and ischemic stroke in the young

Jukka Putaala(University of Helsinki), Turgut Tatlisumak(University of Gothenburg), Per‐Henrik Groop(University of Helsinki), Daniel Gordin(Helsinki University Hospital), Ron Liebkind(Institute of Genetics), Lena M. Thorn(University of Helsinki), Markku Kaste(University of Helsinki), Elena Haapaniemi(Institute of Genetics), Carol Forsblom(University of Helsinki)

Neurology

May 23, 2011

10.1212/wnl.0b013e31821cccc2

Cited by 108

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

|The Lancet|2014|2.7k

The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes

|Diabetes|2009|641

Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease

|Journal of the American Society of Nephrology|2013|578

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study

|The Lancet Neurology|2008|572

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

|Diabetes|1999|509